BioPace Logo

Optimize Clinical Trial Protocols with AI

BioPace helps pharmaceutical companies and CROs reduce costly amendments and accelerate time-to-market with AI-powered protocol intelligence.

Request a Demo Learn More
The Protocol Challenge

Clinical Trial Bottlenecks

Protocol complexity has become a silent crisis in global healthcare, creating significant bottlenecks in bringing life-saving therapies to patients.

0%

Protocols Requiring Amendments

Protocols undergoing at least one substantial amendment.

£0k

Cost Per Amendment

Average cost of each substantial protocol amendment.

0 Months

Time Delay

Average delay in time-to-market per amendment.

0%

Recruitment Impact

Potential decrease in patient enrollment due to complexity.

1

Complex Eligibility Criteria

Overly restrictive or ambiguous eligibility criteria lead to recruitment challenges and increased screen failures.

2

Costly Amendments

When issues are discovered during the trial, substantial amendments are required, each costing an average of £350,000.

3

Trial Delays

Protocol complexity delays trials by up to three months, directly impacting patient access to potentially life-saving therapies.

The Human Cost

Every month of delay in clinical trials has real human impact. For terminal illnesses, a 3-month delay can mean:

Thousands of patients waiting for potentially life-saving treatments

For diseases with poor prognosis, time is the most critical factor

Even for non-terminal conditions, quality of life improvements are delayed

Patients continue to suffer with symptoms that could be alleviated sooner

BioPace exists to solve this crisis
Our Solution

AI-Powered Protocol Intelligence

BioPace serves as an intelligent co-pilot for protocol development, helping you create clearer, more operationally feasible protocols before trials begin.

1

Upload Your Protocol

Upload your draft protocol document in Word, PDF, or structured format.

Secure encryption All formats
2

AI-Powered Analysis

Our algorithms analyze every aspect of your protocol, identifying issues before they impact your trial.

Complexity Analysis

Identify high-complexity areas

Risk Assessment

Flag potential recruitment risks

3

Smart Recommendations

Receive data-driven suggestions while maintaining regulatory compliance.

!

Example:

"Consider broadening age range and removing overly restrictive lab parameters."

4

Implement & Iterate

Make informed revisions and re-analyze until your protocol is optimized.

Result: 70% fewer amendments
BioPace Protocol Intelligence Dashboard

Protocol Complexity Assessment

Cancer Study XB-217

Overall Complexity Score

Updated 2 min ago
0 (Simple) 78% - High 100 (Complex)

Eligibility

Critical: 12 issues

Visit Schedule

Medium severity

Amendment Risk

High risk: 82%

Recruitment

Est. -34% impact

Top Recommendations

  • 1

    Simplify inclusion criteria #3 and #7

    Broaden eligible population (+28%)

  • 2

    Reduce frequency of measurements

    Consolidate visits 4, 5, and 7

  • 3

    Clarify ambiguous language

    Add specific guidance in section 4.2

How BioPace Transforms Protocol Development

Proactive, Not Reactive

Identify and resolve issues before your trial begins, not after costly amendments are required.

Data-Driven Decisions

Replace subjective opinions with quantitative analysis based on industry data and AI insights.

Time & Cost Savings

Accelerate time-to-market by 3+ months and save £350k+ per avoided amendment.

Ready to Optimize Your Clinical Trial Protocols?

Contact us to learn more about how BioPace can help reduce protocol amendments, improve site engagement, and accelerate time-to-market.

OUR VISION

Accelerating Medical Innovation

We're committed to helping pharmaceutical companies and CROs bring life-saving therapies to patients faster.

Patient Impact

Even modest time savings can have significant health impacts. Accelerating the availability of a cancer therapy by three months could translate to thousands of lives extended or improved.

Healthcare Crisis

Protocol complexity has become a silent crisis in global healthcare. Our goal is to address this bottleneck in the development of life-saving treatments through intelligent protocol optimization.

Inclusive Trials

Simplified protocols enhance the trial experience for both participants and healthcare professionals. By flagging overly restrictive eligibility criteria, we help make clinical trials more accessible and diverse.

Get in Touch